Our Testimonials
See what our customers have siad about the research papers that we have provided.
| Testimonials |
|---|
| "Dr. Cheryl Barton of Pharmavision recently presented at a global management conference for West. Our goal was to understand how the many advances across the broad vaccine spectrum would impact our core injectable business as well as our future innovation plans. We shared our base understanding of the vaccine market and our long range growth platforms with Dr. Barton and her team at Pharmavision and they crafted a very insightful overview of the industry highlighting key areas of interest. The result was an outstanding interactive presentation. Feedback across West has been very positive and has led to additional research opportunities between West and Pharmavision. Glen Zimmermann Manager, Strategic Marketing Initiatives West Pharmaceutical Services 101 Gordon Drive, Lionville PA 19341 USA"
West Pharmaceutical Services
|
| "Espicom Business Intelligence has enjoyed a successful and much valued collaborative relationship with Dr. Cheryl Barton since 2004. Working together on a variety of projects covering the CNS, Oncology and Drug Delivery sectors has resulted in the launch of a highly acclaimed series of market intelligence reports which offer a fresh and independent perspective through proprietary analysis and sales forecasts. Ian Taylor, Research Director, Espicom Business Intelligence City Fields Business Park, Chichester, PO20 2FS, United Kingdom "
Espicom Business Intelligence
|
| "“Pharmavision have provided us with high quality, commercially valuable and timely analysis for several years as research partners for Business Insights. We have always been impressed by their professionalism and diligence in providing bespoke research and analysis services.” Gaurav Misra Business Insights Head of Healthcare Analysis London "
Business Insights
|
| "Volume 6 / Number 12 / December 2007 Technology Trends to Watch in 2008 Reverse genetics Interest in personalized medicine hasn't been lost on incumbent biotech giants, like Roche,Abbott Laboratories [ABT] and Siemens AG [SI]. Many of them are launching initiatives that combine in vitro diagnostics with therapeutic solutions in one procedure, according to Dr Cheryl Barton, founder of U.K. consultant firm PharmaVision. Targeted carrier systems represented about half of the $6.5 billion market for advanced drug delivery in 2006, reported Barton. By 2015, the sector could see nearly thirty new commercial therapies focusing on treatment for cancer, cardiovascular and infectious disease. "
Forbes/Wolfe Emerging Tech Report
|